🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
We Can Medicines Co., Ltd. (TPEX:6929)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.95
-0.90 (-4.32%)
Nov 19, 2026, 12:36 PM CST

We Can Medicines Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-69.59-73.21-47.1814.8100.0538.79
Depreciation & Amortization
314.86318.45306.87274.49252.03212.89
Other Amortization
2.252.252.211.691.520.87
Loss (Gain) From Sale of Assets
2.847.080.142.777.21.85
Asset Writedown & Restructuring Costs
11.863.84.423.68-
Loss (Gain) From Sale of Investments
-0.28-0.47-0.37--0.11-0.19
Stock-Based Compensation
-0.351.295.079.984.11-
Provision & Write-off of Bad Debts
-1.160.3-0.12-2.43.940.1
Other Operating Activities
20.6722.2118.9322.9239.9214.38
Change in Accounts Receivable
0.56-14.9647.61-83.48-14.72-54.84
Change in Inventory
-11.54.92-74.06-86.76-106.48-54.09
Change in Accounts Payable
1.964.91-30.9427.2877.89150.23
Change in Unearned Revenue
2.490.860.79-3.43-1.63-1.97
Change in Other Net Operating Assets
26.22.5226.94-40.03-20.84-1.04
Operating Cash Flow
341.34240.02260.68139.84346.67457.16
Operating Cash Flow Growth
14.29%-7.92%86.41%-59.66%-24.17%478.31%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-32.34-35.53-63.95-92.55-122.54-339.58
Sale of Property, Plant & Equipment
0.3-0.31---
Sale (Purchase) of Intangibles
-1.2-0.4-5.29-1.4-0.38-3.37
Other Investing Activities
3.121.51-0.11-4.5-5.53-2.81
Investing Cash Flow
-80.15-34.42-69.04-98.45-128.45-345.76

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-855551,0502656
Long-Term Debt Issued
-10---150
Total Debt Issued
135955551,050265156
Short-Term Debt Repaid
--85-690-915-265-6
Long-Term Debt Repaid
--252.56-238.09-211.89-188.45-164.98
Lease Payments
-250.7-245.41-231.07-206.68-188.45-164.98
Total Debt Repaid
-382.97-337.56-928.09-1,127-453.45-170.98
Net Debt Issued (Repaid)
-247.97-242.56-373.09-76.89-188.45-14.98
Issuance of Common Stock
0.84.58356.37---
Common Dividends Paid
---12---
Other Financing Activities
-26.1-27.94-17.78-20.23-16.88-13.23
Financing Cash Flow
-273.26-265.92-46.5-97.12-205.32-28.21

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-12.07-60.31145.15-55.7312.983.18

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
308.99204.5196.7347.29224.13117.58
Free Cash Flow Growth
19.16%3.95%316.03%-78.90%90.63%458.55%
Free Cash Flow Margin
9.57%6.35%6.02%1.51%6.79%4.21%
Free Cash Flow Per Share
6.814.544.531.125.372.94
Levered Free Cash Flow
252.66229.38156.69-2.81141.92-72.62
Unlevered Free Cash Flow
267.63245.38173.8411.86153.84-63.6
Free Cash Flow After Leases
58.29-40.92-34.34-159.3935.68-47.4

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
25.6125.6127.4323.4519.0614.37
Cash Income Tax Paid
0.080.085.636.72--
Change in Working Capital
60.24-41.68-29.28-186.41-65.68188.47